Horan, W. P., Sauder, C., Harvey, P. D., Ramsay, I. S., Yohn, S. E., Keefe, R. S. E., … Brannan, S. K. (2025). The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials. American Journal of Psychiatry, 182(3), 297–306. https://doi.org/10.1176/appi.ajp.20240076

Horan, William P., Colin Sauder, Philip D. Harvey, Ian S. Ramsay, Samantha E. Yohn, Richard S. E. Keefe, Vicki G. Davis, Steven M. Paul, and Stephen K. Brannan. “The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials.” American Journal of Psychiatry 182, no. 3 (March 1, 2025): 297–306. https://doi.org/10.1176/appi.ajp.20240076.

Horan WP, Sauder C, Harvey PD, Ramsay IS, Yohn SE, Keefe RSE, et al. The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials. American Journal of Psychiatry. 2025 Mar 1;182(3):297–306.

Horan, William P., et al. “The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials.” American Journal of Psychiatry, vol. 182, no. 3, American Psychiatric Association Publishing, Mar. 2025, pp. 297–306. Crossref, doi:10.1176/appi.ajp.20240076.

Horan WP, Sauder C, Harvey PD, Ramsay IS, Yohn SE, Keefe RSE, Davis VG, Paul SM, Brannan SK. The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials. American Journal of Psychiatry. American Psychiatric Association Publishing; 2025 Mar 1;182(3):297–306.